Heike Zieher

572 citations
6 papers · 496 indexed · h-index 4

Heike Zieher

6 papers receiving 490 citations

Peers

Heike Zieher
Comparison fields: 5 of 65
  • Immunology and Allergy 81
  • Cancer Research 141
  • Genetics 61
  • Oncology 116
  • Radiology, Nuclear Medicine and Imaging 96
Replace Kristin Gurtner with:
Kristin Gurtner Germany
Francesca Iommelli Italy
Karin Mengele Germany
Steven King United States
S. Ménard Canada
Sai Duriseti United States
Hendrica A.J.M. Prevoo Netherlands
Trude G. Simonsen Norway
Lele Zhang China
Elise R. Bender United States
Heike Zieher relative to Kristin Gurtner Germany Kristin Gurtner's profile →
Citations per field
00.5×1.5×2.4×
Kristin Gurtner · 1×
Citations per year

Countries citing papers authored by Heike Zieher

Since Specialization
Citations

This map shows the geographic impact of Heike Zieher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Zieher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Zieher more than expected).

Fields of papers citing papers by Heike Zieher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Zieher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Zieher. The network helps show where Heike Zieher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Heike Zieher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heike Zieher Line = papers co-authored together Heike Zieher links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 2008116
2 2005179
3 200463
4
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
2003135
5 20031
6 20032

About Heike Zieher

Heike Zieher is a scholar working on Immunology and Allergy, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 6 papers that have together received 496 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Effects of Radiation Exposure (2 papers), Ultrasound and Hyperthermia Applications (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Immunology and Allergy (81 citations), Cancer Research (141 citations) and Genetics (61 citations). Heike Zieher has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Peter E. Huber, Amir Abdollahi, Kenneth E. Lipson, Alexandra Roth, Jürgen Debus, Rainer Saffrich, Dennis E. Hallahan, Ralph A. Reisfeld, Andreas G. Niethammer and Hermann‐Josef Gröne. Their work appears in journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Investigative Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026